IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.089
EU - Europa 2.472
AS - Asia 739
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.086
IE - Irlanda 758
SE - Svezia 674
CN - Cina 362
UA - Ucraina 330
SG - Singapore 326
DE - Germania 202
IT - Italia 168
FI - Finlandia 114
GB - Regno Unito 85
PL - Polonia 50
IN - India 27
AT - Austria 19
FR - Francia 18
RU - Federazione Russa 17
BE - Belgio 16
IR - Iran 10
NL - Olanda 7
CZ - Repubblica Ceca 6
AU - Australia 4
VN - Vietnam 4
CA - Canada 3
KR - Corea 3
CH - Svizzera 2
EU - Europa 2
IQ - Iraq 2
NO - Norvegia 2
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 6.310
Salva come PNG Salva come JPEG
Città #
Dublin 758
Jacksonville 617
Chandler 600
Nyköping 437
Dearborn 390
Singapore 242
Beijing 160
Princeton 120
Medford 116
Cambridge 109
Ashburn 105
Ann Arbor 81
Boardman 78
Des Moines 72
Messina 51
Warsaw 48
San Mateo 34
Woodbridge 33
Jinan 30
Wilmington 28
New York 24
Lancaster 23
Vienna 18
Brussels 16
Haikou 15
Nanjing 13
Seattle 13
Los Angeles 12
Shenyang 12
Hefei 11
Taizhou 11
Tianjin 11
Francofonte 10
Hebei 10
Houston 10
Taiyuan 10
Ardabil 8
Fuzhou 8
Guangzhou 8
Nanchang 8
Pune 8
Washington 8
Auburn Hills 6
Helsinki 6
Norwalk 6
Bremen 5
Brno 5
Ningbo 5
Reggio Calabria 5
Turin 5
Augusta 4
Changsha 4
Dong Ket 4
Hangzhou 4
Milan 4
Monmouth Junction 4
Riva 4
Saint Petersburg 4
Aci Catena 3
Amsterdam 3
Chengdu 3
Chuncheon 3
Clearwater 3
Den Haag 3
Falls Church 3
Fontaniva 3
Hyderabad 3
Kunming 3
Mountain View 3
Mumbai 3
Pietra Ligure 3
Baghdad 2
Büdelsdorf 2
Catania 2
Cupertino 2
Hanover 2
Jiaxing 2
Lanzhou 2
Nuremberg 2
Santa Clara 2
Scanzano Jonico 2
Serra 2
Shanghai 2
Torino 2
Zhengzhou 2
Aarau 1
Aci Sant'antonio 1
Amman 1
Ancona 1
Belgrade 1
Berlin 1
Bogotá 1
Borghetto Santo Spirito 1
Cagliari 1
Canberra 1
Canton 1
Carrara 1
Cascina 1
Chiavari 1
Chongqing 1
Totale 4.533
Salva come PNG Salva come JPEG
Nome #
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 96
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 79
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 78
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 78
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 76
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 76
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 76
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 75
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 74
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 71
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 71
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 70
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 69
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 69
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 69
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 68
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 68
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 67
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 67
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 67
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 67
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 65
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 65
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 64
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 64
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 64
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 64
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 64
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 63
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 63
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 63
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 62
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 62
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 62
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 62
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 61
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 60
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 60
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 59
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 59
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 59
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 59
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 58
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 58
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 58
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 58
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 58
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 58
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 57
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 57
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 57
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 57
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 57
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 57
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 56
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 56
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 56
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 56
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 56
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 56
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 55
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 55
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 55
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 54
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 54
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 53
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 52
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 52
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 52
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 52
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 52
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 52
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 51
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 51
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 50
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 50
null 50
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 49
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 49
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 49
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 49
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 48
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 48
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 48
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 48
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 47
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 46
Synthesis of mono- and di-cyanoborane adducts from isonicotinoylhydrazones and sodium cyanoborohydride 46
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 46
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 46
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 45
Chondroprotective activity of 5-arylidene-4-thiazolidinone derivatives as new inhibitors of matrix metalloproteinase-13 45
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 45
Inibitori COX-2 selettivi a struttura tiazolidinonica 44
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 44
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 43
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 43
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 43
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 43
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 42
Totale 5.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020575 0 0 0 0 0 0 253 118 22 49 126 7
2020/2021766 125 15 112 38 28 99 12 82 28 105 83 39
2021/2022700 6 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/2025378 21 21 41 135 82 38 40 0 0 0 0 0
Totale 6.381